Mirati Therapeutics (MRTX) PT Lowered to $105 at Stifel, Buy Rating Maintained, "Negative After-Market Move is Overdone"

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

Go back to Mirati Therapeutics (MRTX) PT Lowered to $105 at Stifel, Buy Rating Maintained, "Negative After-Market Move is Overdone"

Mirati Therapeutics (MRTX) Halted on Volatility, Down 40%

May 27, 2022 9:44 AM EDT

Mirati Therapeutics (NASDAQ: MRTX) Halted on Volatility, Down 40%

... More